Omega Competitors

OHI Stock

USD 46.57 0.04 0.09%

Omega Healthcare Inv competes with Healthpeak Properties, Gaming Leisure, Regency Centers, Lamar Advertising, and American Homes; as well as few others. The company runs under Diversified REITs sector within Real Estate industry. Analyzing Omega Healthcare competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Omega Healthcare to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Omega Healthcare Correlation with its peers.

Omega Healthcare vs Rithm Capital Correlation

Excellent diversification

The correlation between Omega Healthcare Investors and RITM is -0.55 (i.e., Excellent diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Omega Healthcare Investors and RITM in the same portfolio, assuming nothing else is changed.

Moving together with Omega Stock

0.81

Healthcare Realty Trust

Pair Corr

Moving against Omega Stock

0.38

6CL

DigitalBridge Group Earnings Call This Week

Pair Corr

Specify up to 10 symbols:

Hype

Prediction

Low	Estimated	High
45.17	46.52	47.87

Details

Intrinsic

Valuation

Low	Real	High
42.08	43.43	51.23

Details

Naive

Forecast

Low	Next	High
47.53	48.88	50.23

Details

Bollinger

Band Projection (param)

Lower	Middle Band	Upper
25.71	46.38	67.05

Details

Please note, it is not enough to conduct a financial or market analysis of a single entity such as Omega Healthcare. Your research has to be compared to or analyzed against Omega Healthcare's peers to derive any actionable benefits. When done correctly, Omega Healthcare's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Omega Healthcare Inv.

Omega Healthcare Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Omega Healthcare and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of Omega and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Omega Healthcare Inv does not affect the price movement of the other competitor.

	DOC	GLPI	REG	LAMR	AMH	ELS	NLY	KIM	RITM
DOC		0.0	0.26	0.5	0.15	0.31	0.41	0.19	0.46	DOC
GLPI	0.0		0.5	0.12	0.27	0.46	0.61	0.48	-0.18	GLPI
REG	0.26	0.5		0.68	-0.05	0.93	0.37	0.94	-0.19	REG
LAMR	0.5	0.12	0.68		-0.12	0.7	0.19	0.7	-0.03	LAMR
AMH	0.15	0.27	-0.05	-0.12		-0.09	0.17	-0.12	0.18	AMH
ELS	0.31	0.46	0.93	0.7	-0.09		0.26	0.93	-0.24	ELS
NLY	0.41	0.61	0.37	0.19	0.17	0.26		0.32	0.56	NLY
KIM	0.19	0.48	0.94	0.7	-0.12	0.93	0.32		-0.2	KIM
RITM	0.46	-0.18	-0.19	-0.03	0.18	-0.24	0.56	-0.2		RITM
	DOC	GLPI	REG	LAMR	AMH	ELS	NLY	KIM	RITM

High positive correlations

KIM	+ 0.94	REG
ELS	+ 0.93	REG
KIM	+ 0.93	ELS
ELS	+ 0.7	LAMR
KIM	+ 0.7	LAMR
LAMR	+ 0.68	REG

High negative correlations

RITM	- 0.24	ELS
RITM	- 0.2	KIM
RITM	- 0.19	REG
RITM	- 0.18	GLPI
KIM	- 0.12	AMH
AMH	- 0.12	LAMR

Risk-Adjusted Indicators

There is a big difference between Omega Stock performing well and Omega Healthcare Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Omega Healthcare's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
DOC	1.14	(0.07)	0.00	(0.18)	0.00	0.00	2.19	(2.74)	6.68
GLPI	0.95	0.19	0.11	(1.36)	0.88	(1.17)	2.67	(1.80)	5.95
REG	0.84	0.15	0.10	1.01	0.73	(0.98)	2.10	(1.32)	4.33
LAMR	0.88	0.04	0.00	0.18	0.99	(0.93)	2.20	(1.76)	4.83
AMH	1.06	(0.13)	0.00	(0.41)	0.00	0.00	2.02	(2.05)	7.05
ELS	0.81	0.14	0.07	(22.16)	0.75	(0.85)	2.21	(1.56)	4.37
NLY	0.87	0.11	0.05	0.40	1.06	(0.92)	2.39	(1.46)	6.58
KIM	0.93	0.19	0.13	0.91	0.85	(1.04)	1.98	(1.74)	5.04
RITM	1.03	(0.11)	0.00	(0.07)	0.00	0.00	2.15	(1.75)	11.83

Omega Healthcare Competitive Analysis

The better you understand Omega Healthcare competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Omega Healthcare's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Omega Healthcare's competition over several years is one of the best ways to analyze its investment potential.

Better Than Average

Worse Than Peers

View Performance Chart

	OHI	DOC	GLPI	REG	LAMR	AMH	ELS	NLY	KIM	RITM
	0.09 46.57 Omega	0.41 16.99 Healthpeak	0.21 47.25 Gaming	1.37 76.85 Regency	0.87 133.98 Lamar	4.37 29.52 American	0.60 67.55 Equity	0.17 23.02 Annaly	2.66 23.17 Kimco	1.23 10.45 Rithm
Market Volatility (90 Days Market Risk)	Very steady	Very steady	Very steady	Very steady	Very steady	Very steady	Very steady	Very steady	Very steady	Not too volatile
Market Performance (90 Days Performance)	Mild	Weakest	Good	Good	Weak	Weakest	Fair	Fair	Good	Weakest
Odds of Financial Distress (Probability Of Bankruptcy)	Tiny	Small	Tiny	Small	Small	Small	Low	Tiny	Tiny	Low
Current Valuation (Equity Enterprise Value)	Over Valued	Fairly Valued	Fairly Valued	Fairly Valued	Fairly Valued	Under Valued	Over Valued	Fairly Valued	Fairly Valued	Under Valued
Buy or Sell Advice (Average Analysts Consensus)	Not Available	Not Available	Not Available	Strong Buy	Buy	Buy	Strong Buy	Not Available	Buy	Strong Buy
Trade Advice (90 Days Macroaxis Advice)	Strong Sell	Buy	Strong Sell	Strong Buy	Strong Buy	Strong Buy	Hold	Buy	Strong Buy	Strong Hold
Current Ratio	2.57	1.58	19.57	0.95	0.64	2.12	0.28	0.25	76.2	1.59
Net Asset	10.05 B	20.34 B	13.33 B	13 B	6.93 B	12.47 B	5.75 B	135.61 B	19.69 B	53.07 B
Profit Margin	0.5	0.0253	0.49	0.33	0.19	0.25	0.25	0.85	0.27	0.22
EBITDA	1.17 B	1.6 B	1.45 B	980.61 M	48.6 K	504.34 M	607.68 M	6.87 B	1.53 B	1.63 B
Operating Margin	0.63	0.2	0.85	0.39	0.32	0.24	0.36	0.94	0.33	0.22
Current Valuation	18.24 B	21.28 B	19.89 B	19.39 B	18.11 B	16.55 B	16.31 B	134.15 B	23.31 B	41.62 B
Price To Book	2.7	1.55	2.87	2.09	12.93	1.64	7.41	1.16	1.46	0.83
Retained Earnings	(3.62 B)	(5.95 B)	(1.94 B)	(1.99 B)	(1.11 B)	(387.64 M)	(225.04 M)	(13.16 B)	(528.73 M)	(19.95 M)
Current Asset	223.89 M	6.12 M	107.5 M	175.88 M	281.73 M	168.97 M	146.59 M	N/A	372.35 M	N/A
Five Year Return	8.16	5.3	6.59	3.97	4.26	0.91	2.03	11.78	5.58	11.51
Beta	0.55	1.11	0.68	0.94	1.25	0.8	0.77	1.3	1.08	1.2
Number Of Employees	69	411	19	503	3.5 K	1.73 K	3.8 K	212	717	6.04 K
Shares Outstanding	295.57 M	695.04 M	283.01 M	182.91 M	86.86 M	370.47 M	193.84 M	718.39 M	674.09 M	555.88 M
Cash Flow From Operations	878.55 M	1.25 B	1.07 B	827.69 M	864.05 M	864.33 M	571.15 M	692.91 M	1.12 B	(2.19 B)
Annual Yield	0.0573	0.0715	0.0668	0.0398	0.0467	0.0398	0.0323	0.12	0.0459	0.0945
Total Debt	4.26 B	10.44 B	8.04 B	5.94 B	1.75 B	4.74 B	3.37 B	111.86 B	8.43 B	39.32 B
Return On Equity	0.12	0.0116	0.17	0.0768	0.39	0.0661	0.22	0.14	0.0554	0.0837
Return On Asset	0.0466	0.0166	0.0563	0.0315	0.0507	0.0212	0.0581	0.0172	0.0224	0.0145
Number Of Shares Shorted	12.43 M	27.34 M	10.87 M	6.86 M	3.59 M	10.68 M	8.27 M	13.27 M	23.09 M	9.49 M
Book Value Per Share	17.53	10.79	16.17	36.63	10.2	19.3	9.06	20.21	15.42	12.66
Current Liabilities	15.35 M	21.43 M	83.82 M	193.94 M	236.83 M	291.59 M	281.66 M	N/A	4.03 B	N/A
Total Asset	10.05 B	20.34 B	13.33 B	13 B	6.93 B	12.47 B	5.75 B	135.61 B	19.69 B	53.07 B
Debt To Equity	1.35	0.68	1.61	0.64	3.59	0.63	2.19	5.82	0.74	3.4
Short Ratio	6.66	2.93	4.55	5.35	8.52	2.34	4.85	1.45	4.49	1.01
Target Price	48.38	19.88	53.89	80.3	134.8	36.6	69.62	24.45	24.26	14.5
Last Dividend Paid	2.68	1.22	3.08	2.87	N/A	1.16	2.06	2.8	1.01	1.0
Shares Owned By Institutions	81.35	97.48	97.49	99.28	99.37	90.45	98.67	60.0	97.14	54.2
Market Capitalization	14.13 B	11.86 B	13.22 B	14.35 B	13.57 B	13.04 B	13.45 B	16.51 B	15.28 B	5.88 B
Price To Earning	30.17	45.38	21.58	252.92	41.87	117.36	52.19	2.82	78.74	4.11
Price To Earnings To Growth	1.13	4.08	8.08	2.7	7.43	29.82	5.09	-3.61	3.37	0.44
Price To Sales	11.88	4.2	8.38	8.91	6.02	7.12	8.75	6.93	7.14	1.87
Net Income	609.47 M	101.03 M	784.16 M	527.46 M	587.15 M	439.03 M	386.51 M	2.03 B	584.74 M	125.87 M
Earnings Per Share	1.93	0.1	2.79	2.82	4.25	1.18	2.01	2.92	0.82	1.04
Shares Owned By Insiders	0.19	0.29	4.18	0.72	2.2	7.75	1.33	0.09	2.16	0.68
Revenue	1.2 B	2.82 B	1.53 B	1.55 B	100 K	1.83 B	1.53 B	7.13 B	2.14 B	5.18 B
Working Capital	1.46 B	(506.59 M)	3.42 B	(100.6 M)	(353.21 M)	(1.6 M)	(618.93 M)	N/A	744.21 M	N/A
Cash And Equivalents	27.02 M	467.46 M	59.03 M	122.01 M	91.69 M	199.41 M	27.78 M	2.04 B	212.79 M	1.71 B
Cash Per Share	0.7	0.01	0.23	0.71	0.9	0.2	0.15	4.8	0.2	3.65
Gross Profit	1.17 B	1.69 B	1.48 B	1.15 B	1.51 B	1.03 B	818.22 M	2.32 B	1.48 B	3.14 B
Day Typical Price	46.6	16.94	47.4	76.45	131.69	30.09	67.24	22.97	22.96	10.5
Accumulation Distribution	13206.92	133604.0	96168.11	14783.35	67453.56	438857.0	14738.53	84930.96	239890.0	108006.0
Daily Balance Of Power	0.0702	(0.22)	(0.08)	0.8455	0.1467	(0.60)	0.396	0.1429	0.9091	(0.81)
Period Momentum Indicator	0.04	(0.07)	(0.10)	1.04	1.15	(1.35)	0.4	0.04	0.6	(0.13)
Rate Of Daily Change	1.0	1.0	1.0	1.01	1.01	0.96	1.01	1.0	1.03	0.99
Day Median Price	46.61	16.92	47.48	76.25	130.54	30.37	67.09	22.95	22.86	10.53
Price Action Indicator	(0.03)	0.035	(0.28)	1.12	4.01	(1.53)	0.66	0.09	0.61	(0.15)
Relative Strength Index	48.15	49.65	46.68	69.36	47.35	47.22	58.35	40.63	60.78	35.22
Coefficient Of Variation	1517.53	(3,758)	633.3	598.02	1444.79	(1,443)	719.44	866.66	535.13	(3,374)
Mean Deviation	0.931	1.14	0.948	0.839	0.8771	1.06	0.8074	0.8729	0.9265	1.03
Jensen Alpha	0.1177	(0.07)	0.194	0.1515	0.0405	(0.13)	0.1356	0.1077	0.1916	(0.11)
Total Risk Alpha	(0.05)	(0.19)	0.0705	0.0672	(0.04)	(0.24)	0.0386	0.0179	0.1	(0.20)
Sortino Ratio	0.0061	N/A	0.1084	0.0991	(0)	N/A	0.0652	0.0464	0.128	N/A
Downside Variance	1.81	N/A	1.1	0.8681	1.14	N/A	0.9839	1.68	1.15	N/A
Standard Deviation	1.35	1.53	1.23	1.03	1.12	1.4	1.04	1.22	1.17	1.59
Kurtosis	6.13	0.6401	0.3604	(0.53)	(0.21)	1.12	(0.09)	1.98	(0.31)	10.12
Potential Upside	1.46	2.19	2.67	2.1	2.2	2.02	2.21	2.39	1.98	2.15
Treynor Ratio	(0.14)	(0.18)	(1.36)	1.01	0.1752	(0.41)	(22.16)	0.3995	0.9099	(0.07)
Maximum Drawdown	8.52	6.68	5.95	4.33	4.83	7.05	4.37	6.58	5.04	11.83
Variance	1.81	2.33	1.52	1.07	1.26	1.97	1.09	1.49	1.36	2.52
Market Risk Adjusted Performance	(0.13)	(0.17)	(1.35)	1.02	0.1852	(0.40)	(22.15)	0.4095	0.9199	(0.06)
Risk Adjusted Performance	0.0546	(0.02)	0.1242	0.1301	0.056	(0.05)	0.1087	0.0917	0.1459	(0.02)
Skewness	1.15	(0.42)	0.3235	0.1776	0.2116	(0.50)	0.2542	(0.52)	0.0884	(1.79)
Semi Deviation	1.21	N/A	0.8754	0.7331	0.9926	N/A	0.7501	1.06	0.8491	N/A
Information Ratio	0.0061	(0.08)	0.0925	0.0893	(0)	(0.13)	0.0619	0.0494	0.1178	(0.08)
Value At Risk	(1.87)	(2.74)	(1.80)	(1.32)	(1.76)	(2.05)	(1.56)	(1.46)	(1.74)	(1.75)
Expected Short fall	(0.91)	N/A	(1.17)	(0.98)	(0.93)	N/A	(0.85)	(0.92)	(1.04)	N/A
Downside Deviation	1.35	N/A	1.05	0.9317	1.07	N/A	0.9919	1.3	1.07	N/A
Semi Variance	1.45	N/A	0.7664	0.5374	0.9853	N/A	0.5626	1.12	0.721	N/A

Omega Healthcare Competition Performance Charts

Five steps to successful analysis of Omega Healthcare Competition

Omega Healthcare's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Omega Healthcare Inv in relation to its competition. Omega Healthcare's competition analysis typically involves several steps, including:

Identifying the key players in the market: This involves identifying the major competitors of Omega Healthcare in the market, both direct and indirect, as well as new entrants and disruptive technologies.
Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Omega Healthcare's competitive landscape.
Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Omega Healthcare Inv, and developing a strategy to address them.
Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.

Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Omega Healthcare position

In addition to having Omega Healthcare in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Volatility ETFs Thematic Idea Now

Volatility ETFs

ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Volatility ETFs theme has 25 constituents at this time.

You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Volatility ETFs Theme or any other thematic opportunities.

View All Next

Launch

When determining whether Omega Healthcare Inv offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Omega Healthcare's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Omega Healthcare Investors Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Omega Healthcare Investors Stock:

How To Invest In Omega

Details

Is Omega Stock a good investment?

Details

What is Omega Healthcare's Net Worth?

Details

Largest Diversified REITs Companies

View

Largest Equity Real Estate Investment Trusts (REITs) Companies

View

Check out Omega Healthcare Correlation with its peers.

You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.

Is there potential for Diversified REITs market expansion? Will Omega introduce new products? Factors like these will boost the valuation of Omega Healthcare. Anticipated expansion of Omega directly elevates investor willingness to pay premium valuations. Understanding fair value requires weighing current performance against future potential. All the valuation information about Omega Healthcare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Omega Healthcare Inv is measured differently than its book value, which is the value of Omega that is recorded on the company's balance sheet. Investors also form their own opinion of Omega Healthcare's value that differs from its market value or its book value, called intrinsic value, which is Omega Healthcare's true underlying value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Because Omega Healthcare's market value can be influenced by many factors that don't directly affect Omega Healthcare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

It's important to distinguish between Omega Healthcare's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Omega Healthcare should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Omega Healthcare's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2026 Macroaxis LLC

Omega Competitors

Omega Healthcare vs Rithm Capital Correlation

Excellent diversification

Moving together with Omega Stock

Moving against Omega Stock

Specify up to 10 symbols:

Omega Healthcare Competition Correlation Matrix

High positive correlations

High negative correlations

Risk-Adjusted Indicators

Omega Healthcare Competitive Analysis

Omega Healthcare Competition Performance Charts

Five steps to successful analysis of Omega Healthcare Competition

Complement your Omega Healthcare position

Did You Try This Idea?

Run Volatility ETFs Thematic Idea Now

Volatility ETFs

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY